We are pleased to share with you that we will work with Huawei, a leading global information and communications technology provider, as our key public cloud technology partner to support the delivery of China Precision Medicine Initiative (China PMI). Our strategic alliance will put WuXi NextCODE’s world’s leading population genomic system on Huawei’s China’s leading cloud infrastructure. Cloud computing is the way genomic big data will be used to drive precision medicine innovation and deliver better healthcare in a cost-efficient manner. This partnership aims to deliver the benefits of genomic medicine to patients on an unprecedented scale. We will follow the guidance of China Food and Drug Administration (CFDA) and work closely with third-party secure life-science cloud providers to develop the data standards and exchange framework required to deliver the China PMI. We are thrilled to be deploying WuXi NextCODE’s genomics technology with Huawei across China. This is a key part of our strategy to advance a global standard for turning the genome into better health.